Pfizer Limited
NSE: PFIZER | Information Technology
Market Fundamentals
Stock Intelligence & News
EMA validates Pfizer-Valneva Lyme disease vaccine application
EMA validates Pfizer-Valneva Lyme disease vaccine application
Read Full Analysis →Five Stocks To Buy Today: IDFC First Bank, Bank Of Maharashtra, Pfizer Among Others | August 13
Five buzzing stocks of the day
Read Full Analysis →Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock
Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Pfizer grapples with ‘a world of hurt’ after Covid triumph
Sliding vaccine revenues and fears it overpaid for new drugs pile pressure on boss Albert Bourla
Read Full Analysis →Pfizer Inc. Q2 2026 Earnings Call Summary
Pfizer Inc. Q2 2026 Earnings Call Summary
Read Full Analysis →Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
Read Full Analysis →SpaceX, Palantir, AMD, Marvell, Caterpillar, Pfizer, and More Stocks That Explain Today’s Market
SpaceX, Palantir, AMD, Marvell, Caterpillar, Pfizer, and More Stocks That Explain Today’s Market
Read Full Analysis →Pfizer Hikes 2026 Sales Outlook By $500 Million On Second-Quarter Beat
Pfizer Hikes 2026 Sales Outlook By $500 Million On Second-Quarter Beat
Read Full Analysis →Pfizer Q2 Tops Wall Street Estimates, Driven By Surging Sales Of Blood Thinner Eliquis
Outstanding worldwide demand for its popular blood thinner, Eliquis, together with fundamental cost-management initiatives, were the main driver of this outstanding company performance.
Read Full Analysis →Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.
Read Full Analysis →Get instant alerts when PFIZER breaks news
Join investors who track Pfizer Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for PFIZER?
PFIZER is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Pfizer Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding PFIZER to your custom watchlist.